| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 26.367 | 30.425 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 26.367 | 30.438 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 23.120 | 36.518 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | 3.247 | -6.081 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | 2.456 | -6.737 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Employees | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Regal House Intermed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 202 | 200 | 197 | 193 | 190 | 186 | 182 | 183 | 182 | 181 |
| Current Assets | 12.002 | 7.684 | 7.312 | 7.178 | 7.039 | 6.906 | 6.752 | 6.773 | 6.753 | 6.715 |
| Inventories | 6.191 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 68 | 7.684 | 7.312 | 7.178 | 7.039 | 6.906 | 6.752 | 6.773 | 6.753 | 6.715 |
| Cash | 5.743 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders Funds | -559 | -7.290 | -7.167 | -7.036 | -6.899 | -6.769 | -6.618 | -6.639 | -6.619 | -6.582 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 12.764 | 15.175 | 14.676 | 14.407 | 14.128 | 13.860 | 13.553 | 13.595 | 13.554 | 13.478 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2312 - 2312" | |||||||||
| CAEN Financial Year |
2312
|
|||||||||
Comments - Regal House Intermed S.r.l.